trial · primary record
CD7-specific CAR gene-engineered T cells
T-cell Acute Lymphoblastic Leukemia
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Safety of infusion |
| Registry ID | NCT04033302 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:52.694Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04033302
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.